Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 355.10
+3.80 (1.08%)
At close: Oct 22, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 46.22 billion as of October 22, 2026. It is the 14,587th most valuable company in the world and the 857th biggest in India. Its market cap has decreased by 7.36% in one year.
Market Cap
46.22B
Enterprise Value
47.77B
Revenue
1.74B
Global Rank
Country Rank
#857 India
PE Ratio
79.43
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 46.22B, an increase of 132,707.43%. That is a compound annual growth rate of 33.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 46.22B | -4.14% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 242.83B |
| Shilpa Medicare | 168.44B |
| Symbiotec Pharmalab | 76.95B |
| Suven Life Sciences | 75.68B |
| IOL Chemicals and Pharmaceuticals | 50.34B |
| NGL Fine-Chem | 16.41B |
| Bajaj HealthCare | 10.93B |
| Shree Ganesh Remedies | 8.36B |